These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18803170)

  • 1. Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline.
    Yoshimura R; Umene-Nakano W; Ueda N; Ikenouchi-Sugita A; Hori H; Nakamura J
    Hum Psychopharmacol; 2008 Dec; 23(8):707-13. PubMed ID: 18803170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
    Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Katsuki A; Hayashi K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):308-12. PubMed ID: 20005280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
    Yoshimura R; Nakano Y; Hori H; Ikenouchi A; Ueda N; Nakamura J
    Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone in the treatment of psychotic depression.
    Goto M; Yoshimura R; Kakihara S; Shinkai K; Yamada Y; Kaji K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):701-7. PubMed ID: 16580110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
    Gorgulu Y; Caliyurt O
    Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study of risperidone liquid in the acute phase of schizophrenia.
    Yoshimura R; Nakamura J; Shinkai K; Goto M; Yamada Y; Kaji K; Kakihara S; Ueda N; Kohara K; Ninomiya H; Egami H; Maeda H
    Hum Psychopharmacol; 2005 Jun; 20(4):243-8. PubMed ID: 15830401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
    Yoshimura R; Hori H; Sugita A; Ueda N; Kakihara S; Umene W; Nakano Y; Shinkai K; Mitoma M; Ohta M; Shinkai T; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1072-7. PubMed ID: 17459549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.
    Umene-Nakano W; Yoshimura R; Ikenouchi-Sugita A; Hori H; Hayashi K; Ueda N; Nakamura J
    Hum Psychopharmacol; 2009 Jul; 24(5):409-13. PubMed ID: 19548207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.
    Zanardini R; Gazzoli A; Ventriglia M; Perez J; Bignotti S; Rossini PM; Gennarelli M; Bocchio-Chiavetto L
    J Affect Disord; 2006 Mar; 91(1):83-6. PubMed ID: 16448701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline treatment of elderly patients with depression and cognitive impairment.
    Devanand DP; Pelton GH; Marston K; Camacho Y; Roose SP; Stern Y; Sackeim HA
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):123-30. PubMed ID: 12571820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
    Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
    Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.
    Piccinni A; Marazziti D; Catena M; Domenici L; Del Debbio A; Bianchi C; Mannari C; Martini C; Da Pozzo E; Schiavi E; Mariotti A; Roncaglia I; Palla A; Consoli G; Giovannini L; Massimetti G; Dell'Osso L
    J Affect Disord; 2008 Jan; 105(1-3):279-83. PubMed ID: 17553570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
    Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder].
    Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Hayashi K; Katsuki A; Ueda N; Nakamura J
    Seishin Shinkeigaku Zasshi; 2010; 112(10):982-5. PubMed ID: 21179660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants.
    Laske C; Stransky E; Eschweiler GW; Klein R; Wittorf A; Leyhe T; Richartz E; Köhler N; Bartels M; Buchkremer G; Schott K
    J Psychiatr Res; 2007 Oct; 41(7):600-5. PubMed ID: 16600301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.